Patent US4983402A successfully refreshed from Google Patents.
US4983402A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Orally administerable ANF
Assignee: Clinical Technologies Associates Inc
•
Filing: 1989-02-24
•
Granted: 1991-01-08
•
Expires: 2009-02-24
Abstract
Abstract Atrial naturiuretic factor (ANF) is encapsulated within hollow acidic proteinoid microspheres which are stable and protective in the acidic stomach of a mammal but which dissolve at the near neutral pH of the blood. Microspheres having diameters of less than about 10 microns readily penetrate the gastrointestinal mucosa and release the ANF in the bloodstream in physiologically active form. Such gastric administration significantly extends the period of effectiveness of ANF as a diuretic and blood pressure suppressant.
Inventors
- 👤 Solomon S. Steiner
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-02 18:37
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/48; A61K9/50; A61K9/51; A61K9/5107; A61K9/513; A61K9/5146; A61K38/00; A61K38/16; A61K38/17; A61K38/22; A61K38/2242; A61K9/14; A61K9/16; A61K9/1605; A61K9/1629; A61K9/1641
Claims Analysis
Total Claims: 9
Claim 1
Independent Claim
35 words
Orally administerable composition for regulating mammalian blood pressure comprising atrial natriuretic factor encapsulated within acidic proteinoid microspheres having diameters of less than about 10 microns and formed of thermal condensation polymers of mixed amino acids.
Claim 2
Dependent Claim
35 words
Orally administerable composition for regulating mammalian blood pressure comprising atrial natriuretic factor encapsulated within acidic proteinoid microspheres having diameters of less than about 10 microns and formed of thermal condensation polymers of mixed amino acids.
Claim 3
Dependent Claim
18 words
Composition of claim 1 wherein said microspheres are predominantly from about 0.1 to about 5.0 microns in diameter.
Claim 4
Dependent Claim
37 words
Composition of claim 1 wherein said acidic proteinoid is a thermal condensation polymer derived from at least one acidic amino acid selected from glutamic acid and aspartic acid and at least one other naturally occuring amino acid.
Claim 5
Dependent Claim
88 words
Orally administerable composition for delivering atrial natriuretic factor to the bloodstream of a mammal in physiologically active and long lasting form comprising said atrial natriuretic factor encapsulated within acidic proteinoid microspheres having diameters predominantly from about 0.1 to about 5.0 microns, said proteinoid being a thermal condensation polymer derived from about one mol part of acidic amino acid selected from glutamic acid, aspartic acid and mixtures thereof and about one mol part of another amino acid selected from naturally occurring basic and neutral amino acids and mixtures thereof.
Claim 6
Dependent Claim
88 words
Orally administerable composition for delivering atrial natriuretic factor to the bloodstream of a mammal in physiologically active and long lasting form comprising said atrial natriuretic factor encapsulated within acidic proteinoid microspheres having diameters predominantly from about 0.1 to about 5.0 microns, said proteinoid being a thermal condensation polymer derived from about one mol part of acidic amino acid selected from glutamic acid, aspartic acid and mixtures thereof and about one mol part of another amino acid selected from naturally occurring basic and neutral amino acids and mixtures thereof.
Claim 7
Dependent Claim
21 words
Composition of claim 4 wherein said proteinoid is derived from about equimolar parts of glutamic acid, aspartic acid, valine and glycine.
Claim 8
Dependent Claim
65 words
Method for regulating mammalian blood pressure comprising the periodic oral administration to said mammal of a physiologicallly effective amount of atrial natriuretic factor encapsulated within acidic proteinoid microspheres, said acidic proteinoid being stable to stomach acid and unstable at the near neutral pH of the blood, said microspheres being formed of thermal condensation polymers, and said microspheres being less than about 10 microns in diameter.
Claim 9
Dependent Claim
65 words
Method for regulating mammalian blood pressure comprising the periodic oral administration to said mammal of a physiologicallly effective amount of atrial natriuretic factor encapsulated within acidic proteinoid microspheres, said acidic proteinoid being stable to stomach acid and unstable at the near neutral pH of the blood, said microspheres being formed of thermal condensation polymers, and said microspheres being less than about 10 microns in diameter.
References Cited (Backward Citations)
US3076790A
Cited
US3052655A
Cited
US3576758A
Cited
US3822348A
Cited
US3962416A
Cited
US3794561A
Cited
DE2424169A1
Cited
US4351337A
Cited
US4061466A
Cited
EP0000667A1
Cited
US4217370A
Cited
US4272506A
Cited
US4388304A
Cited
JPS5835111A
Cited
US4647455A
Cited
US4492684A
Cited
US4671954A
Cited
US4703042A
Cited
FR2565102A1
Cited
US4753804A
Cited
US4757024A
Cited
US4789734A
Cited
US4844904A
Cited
US4774320A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1994-01-07 | 1994-07-09 | 1995-01-08 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1998-01-07 | 1998-07-09 | 1999-01-08 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2002-01-07 | 2002-07-09 | 2003-01-08 | $7700.00 | Window Closed / Lapsed |